✦ LIBER ✦

Nomogram Score of Pathologic Complete Response to Neoadjuvant Chemoradiation Predicts for Survival Outcomes in Esophageal Cancer Patients Treated With Definitive Chemoradiation

✍ Scribed by Wang, J.; Lin, S.H.; Allen, P.K.; Juloori, A.; Lee, J.K.; Komaki, R.; Liao, Z.; Swisher, S.G.; Hofstetter, W.L.; Ajani, J.A.

Book ID: 122125479
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 59 KB
Volume: 87
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2013.06.224

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Survival outcomes of resected patients w

Survival outcomes of resected patients who demonstrate a pathologic complete response after neoadjuvant chemoradiation therapy for locally advanced esophageal cancer

✍ Z. T. Hammoud; K. A. Kesler; M. K. Ferguson; R. J. Battafarrano; A. Bhogaraju; N 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

Molecular diagnosis of pathologic comple

Molecular diagnosis of pathologic complete response (pCR) to neoadjuvant chemoradiation therapy (CRT) in patients with locally advanced rectal cancer (LARC)

✍ Zhenbin Chen; Wenyan Li; Julio Garcia-Aguilar 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Temporal Patterns of Fatigue Predict Pat

Temporal Patterns of Fatigue Predict Pathologic Response in Patients Treated With Preoperative Chemoradiation Therapy for Rectal Cancer

✍ Hee Chul Park; Nora A. Janjan; Tito R. Mendoza; Edward H. Lin; Saroj Vadhan-Raj; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 286 KB

Long-Term Outcome of Patients with Compl

Long-Term Outcome of Patients with Complete Pathologic Response after Neoadjuvant Chemoradiation for cT3 Rectal Cancer: Implications for Local Excision Surgical Strategies

✍ Claudio Belluco; Antonino De Paoli; Vincenzo Canzonieri; Roberto Sigon; Mara For 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 457 KB

Is a change in patient-reported dysphagi

Is a change in patient-reported dysphagia after induction chemotherapy in locally advanced esophageal cancer a predictive factor for pathological response to neoadjuvant chemoradiation?

✍ Karin Ribi; Dieter Koeberle; Jan C. Schuller; Hanspeter Honegger; Arnaud Roth; V 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 182 KB

EGF61 Polymorphism Predicts Complete Pat

EGF61 Polymorphism Predicts Complete Pathologic Response to Cetuximab-Based Chemoradiation Independent of KRAS Status in Locally Advanced Rectal Cancer Patients

✍ Hu-Lieskovan, S.; Vallbohmer, D.; Zhang, W.; Yang, D.; Pohl, A.; Labonte, M. J.; 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 241 KB